Publication: Aging (Albany NY), peer-reviewed
Study Design: Prospective, controlled study
Participants: 35 healthy adults, average age: 64 years
Location: Sagol Center for Hyperbaric Medicine and Research, Israel
🔍What was observed?
This study demonstrates once again that HBOT has profound effects on cellular aging – this time measured in isolated blood cells, using particularly precise molecular biology methods.
After 60 HBOT sessions (each 90 minutes, 5 times per week, 2 ATA), it was found:
Telomere length increased by up to 38% (especially in T cells)
Old, senescent immune cells (CD28–CD8+) decreased by up to 37%
No medication – pure oxygen therapy with ambient pressure
✨ Highlights & Special Mentions
"HBOT is the first non-pharmacological intervention that has been shown to significantly demonstrate both telomere elongation and reduction in senescence."
✅ Significant rejuvenation of the cellular immune profile
✅ qPCR-based telomere analysis
✅ Improved immune function through reduced senescence
✅ Confirmation of results from the original 2020 telomere study
📌 Good to know
The study utilized modern cell separation & qPCR analysis to specifically evaluate certain cell types (e.g., CD4+, CD8+)
Telomeres are considered one of the most important biomarkers for biological aging
HBOT generates so-called intermittent hyperoxic stimuli that activate the body's own repair mechanisms
"The observed effects suggest a genuine cellular rejuvenation, accompanied by improved immune function."
📈 Conclusion
This study provides another strong argument that HBOT is far more than a symptomatic therapy. It deeply intervenes in cell biology – and, according to data, can partially reverse immune aging.
Study (PDF)
Study (PDF)
Legal Notice Terms and Conditions About Us
X4 Innovation GmbH © 2025 All Rights Reserved
